COMPARISON BETWEEN NORADRENALINE AND PHENYLEPHRINE FOR PREVENTING HYPOTENSION DURING CESAREAN DELIVERY UNDER SPINAL ANAESTHESIA

COMPARISON BETWEEN CONTINUOUS INFUSION OF NORADRENALINE AND PHENYLEPHRINE FOR PREVENTING HYPOTENSION DURING CESAREAN DELIVERY UNDER SPINAL ANAESTHESIA

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020791

Enrollment

Registered

2019-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80-O82- Encounter for delivery

Interventions

Control Intervention1: noradrenaline and phenylephrine: noradrenaline iv @ 0.05mcg/kg/min throughout intraop. phenylephrine iv @ 0.1mcg/kg/min throughout intraop

Eligibility

Inclusion criteria

Inclusion criteria: a) Age greater than or equal to 18 years. b) Willing to provide written informed consent c) Belonging to American Society of Anaesthesiologists ASA grade 1 and 2 d) Singleton pregnancy e) period of gestation more than or equal to 36 weeks

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Primary outcome : prevention of maternal hypotension ( systolic blood pressure less than 80% of baseline value) STimepoint: 4 weeks	—

Secondary

Measure	Time frame
Secondary outcome : prevention of maternal bradycardia ( heart rate less than 60/min)Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Chiranjib Bhattacharyya

IPGMER

bhattach1@yahoo.com9433508030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026